Thailand to extend dose gap for AstraZeneca vaccine to 16 weeks The plan follows a similar decision by Spain to stretch the gap between two AstraZeneca doses to 16 weeks, which is beyond the 12…
Pharma companies need to limit the presence of nitrosamines in human medicines: EMA Patients should generally not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines
Global regulators agree to three priority areas for cooperation on observational research during… High-quality observational research is an important complement to evidence on safety, effectiveness of vaccines, treatments for…
First non-injectable treatment for severe low blood sugar levels The medicine Baqsimi comes in a single-use dispenser which is ready to use and can be administered through the nose by caregivers
‘We are the first company in the world to get a patent for pooled stem cell technology’ Recently, Stempeutics observed the First Stem Cell Awareness Day in India with a public event to explain stem cell therapy options…